Hebei Changshan Biochemical Hits Day High with 5.01% Surge

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. has experienced a notable increase of 5.01% on March 27, 2026, reaching an intraday high of CNY 39.14. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.63% on the same day. Over the past week, Hebei Changshan has shown a slight increase of 0.71%, while the broader market has declined by 1.09%. However, the company's performance over the past month reflects a decline of 17.36%, compared to a 5.99% drop in the Shanghai Composite. In the longer term, Hebei Changshan has demonstrated impressive growth, with a remarkable 90.46% increase over the past year, significantly outperforming the 16.01% rise of the Shanghai Composite. Despite these gains, the company faces challenges, including a high debt-to-equity ratio of 1.54 and operating losses that have impacted its long-term growth potential. The market capitalization stands at CNY 40,221 million, positioning it as a large-cap player in the pharmaceuticals and biotechnology sector.